<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04653753</url>
  </required_header>
  <id_info>
    <org_study_id>kneeSOFT500</org_study_id>
    <nct_id>NCT04653753</nct_id>
  </id_info>
  <brief_title>Assessment of the Safety and Performance of a Patellofemoral Brace</brief_title>
  <official_title>Assessment of the Safety and Performance of a Patellofemoral Brace</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Decathlon SE</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>EFOR, France</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Decathlon SE</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Decathlon has developed kneeSOFT500 product, which is a medical device intended to be used on&#xD;
      the knee to keep a physical activity on a regular basis in case of patellofemoral pain&#xD;
      syndrome or patellar instability. The objective of this multicentre study is to collect data&#xD;
      on the related clinical complications and clinical outcomes of market-approved Decathlon&#xD;
      kneeSOFT500 product to demonstrate safety and performance of this device in a real-world&#xD;
      setting.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional score</measure>
    <time_frame>18 weeks of follow-up</time_frame>
    <description>Comparison of the functional result (Kujala Anterior Knee Pain Scale, 0-100 points) between the baseline and last follow-up visit in each group (orthosis vs control)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Confidence level</measure>
    <time_frame>At baseline and 18 weeks of follow-up</time_frame>
    <description>Gap in the confidence level (patient rated outcome with 6 questions, ranging from 0 to 100) related to physical activity, between the baseline and last follow-up visit in each group (orthosis vs control)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee instability</measure>
    <time_frame>At 6 weeks, 12 weeks and 18 weeks of follow-up</time_frame>
    <description>Comparison of knee instability, assessed through a visual analog scale (VAS, ranging from 0 to 10), between the groups (orthosis vs control)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee pain</measure>
    <time_frame>At 6 weeks, 12 weeks and 18 weeks of follow-up</time_frame>
    <description>Comparison of knee pain, assessed through VAS (ranging from 0 to 10), between the groups (orthosis vs control)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety (adverse events)</measure>
    <time_frame>18 weeks of follow-up</time_frame>
    <description>Comparison of adverse events rates between the groups (orthosis vs control)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Patellofemoral Pain Syndrome</condition>
  <condition>Patellar Instability</condition>
  <arm_group>
    <arm_group_label>Orthosis Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of kneeSOFT500 device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No use of the device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>kneeSOFT500</intervention_name>
    <description>At least 30 patients (15 patients in the orthosis group and 15 patients in the control group) will be included. Patients included in the orthosis group will use the device during sports sessions while patients included in the control group will not use a knee support device.</description>
    <arm_group_label>Orthosis Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is aged ≥18 years old&#xD;
&#xD;
          -  Subject has patellofemoral syndrome&#xD;
&#xD;
          -  The current condition of his/her knee allows the subject to keep a regular physical&#xD;
             activity&#xD;
&#xD;
          -  Subject has been informed and is willing to sign an informed consent form&#xD;
&#xD;
          -  Subject is willing to comply with protocol requirements and return to the study center&#xD;
             for all clinical evaluations and required follow-up (18 weeks)&#xD;
&#xD;
          -  Subject is affiliated to the French social security regime&#xD;
&#xD;
        Non-Inclusion Criteria:&#xD;
&#xD;
          -  Subject has conditions that may interfere with his/her ability to understand protocol&#xD;
             requirements, participate in scheduled visits, or provide his/her informed consent&#xD;
&#xD;
          -  Subject has worn a support (knee brace or articulated orthosis) in the last month&#xD;
             during his/her sport practice&#xD;
&#xD;
          -  Subject has any medical condition that could impact the study at investigator's&#xD;
             discretion&#xD;
&#xD;
          -  Subject has a known hypersensitivity or allergy to the components of the device&#xD;
             (polyamide, cotton, elastane, elastodiene, polyester)&#xD;
&#xD;
          -  Adult subject to a legal protection measure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>André THEVENON</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Régional, Universitaire de Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thibault VIGNAIS</last_name>
    <role>Principal Investigator</role>
    <affiliation>KOSS Paris 8</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Clément OUDART</last_name>
    <role>Principal Investigator</role>
    <affiliation>Physio Sport Levallois</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean HEE</last_name>
    <phone>XX XX XX XX XX</phone>
    <email>jean.hee@btwin.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Physio Sport Levallois</name>
      <address>
        <city>Levallois-Perret</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clément OUDART</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régional Universitaire de Lille</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>André Thevenon, Pr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>September 4, 2020</study_first_submitted>
  <study_first_submitted_qc>November 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 4, 2020</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Patellofemoral Pain Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

